Clinical Trials Browser

Unknown × Hodgkin Disease × Cisplatin × Clear all

NCT02280993 2018-03-13

Phase I/II Feasibility Study Combining Brentuximab Vedotin With Second Line Salvage Chemotherapy (DHAP) in Hodgkin Lymphoma Patients

Phase 1 Unknown

Hodgkin Disease, Recurrence

NCT00025636 2013-09-17

Combination Chemotherapy and Peripheral Stem Cell Transplant in Treating Patients With Relapsed Hodgkin's Lymphoma

Phase 3 Unknown

Hodgkin Disease, Lymphoma